For the week, the S&P 500 climbed, while the 30-stock Dow climbed 1.6%. The tech-laden Nasdaq, meanwhile, surged 2% last week. Wall Street analysts make new stock picks on a daily basis.

On Tuesday, Clear Street analysts reduced the price target for Protagonist Therapeutics (NASDAQ: NASDAQ:PTGX) stock to $62 from $65 while maintaining a Buy rating. The adjustment follows a ...

Learn More » Wall Street thinks Zscaler stock will continue to recover. The majority of the analysts tracked by The Wall Street Journal who cover the stock have assigned it their highest buy ...

Shares of Apple and Tesla have fallen sharply this year, but most Wall Street analysts expect Apple ... I think investors should avoid Apple stock until it either trades at a much cheaper price ...

Billionaire Stanley Druckenmiller of the Duquesne Family Office and Cathie Wood of Ark Invest have both been selling Palantir Technologies stock and ... from some of Wall Street's most-followed ...

Ford (F) stock rose more than 2% on Tuesday afternoon after reporting that sales jumped 16.3% in May to just under 221,000 units. It marked the automaker’s best May since 2019 and the third ...

Moderna (MRNA) stock added more than 3% in premarket trading after the FDA approved its COVID-19 vaccine for individuals 65 and older and those ages 12-64 with an underlying condition. Shares of ...

On the trade front, hopes are still high on Wall Street that Trump will reach trade ... high prices for stocks and other investments. In stock markets abroad, indexes were mixed amid mostly ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...